BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26195629)

  • 41. Structural basis for reactivating the mutant TERT promoter by cooperative binding of p52 and ETS1.
    Xu X; Li Y; Bharath SR; Ozturk MB; Bowler MW; Loo BZL; Tergaonkar V; Song H
    Nat Commun; 2018 Aug; 9(1):3183. PubMed ID: 30093619
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ras signaling requires dynamic properties of Ets1 for phosphorylation-enhanced binding to coactivator CBP.
    Nelson ML; Kang HS; Lee GM; Blaszczak AG; Lau DK; McIntosh LP; Graves BJ
    Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10026-31. PubMed ID: 20534573
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structure of the elk-1-DNA complex reveals how DNA-distal residues affect ETS domain recognition of DNA.
    Mo Y; Vaessen B; Johnston K; Marmorstein R
    Nat Struct Biol; 2000 Apr; 7(4):292-7. PubMed ID: 10742173
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sequence-specific interaction of the Ets1 protein with the long terminal repeat of the human T-lymphotropic virus type I.
    Gitlin SD; Bosselut R; Gégonne A; Ghysdael J; Brady JN
    J Virol; 1991 Oct; 65(10):5513-23. PubMed ID: 1895400
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Auto-inhibition of Ets-1 is counteracted by DNA binding cooperativity with core-binding factor alpha2.
    Goetz TL; Gu TL; Speck NA; Graves BJ
    Mol Cell Biol; 2000 Jan; 20(1):81-90. PubMed ID: 10594011
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The structural and dynamic basis of Ets-1 DNA binding autoinhibition.
    Lee GM; Donaldson LW; Pufall MA; Kang HS; Pot I; Graves BJ; McIntosh LP
    J Biol Chem; 2005 Feb; 280(8):7088-99. PubMed ID: 15591056
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction.
    Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A
    Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Importance of ets1 proto-oncogene for breast cancer progression.
    Dittmer J; Vetter M; Blumenthal SG; Lindemann RK; Kölbl H
    Zentralbl Gynakol; 2004 Aug; 126(4):269-71. PubMed ID: 15389378
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of the transcription factor Ets1 in carcinoma.
    Dittmer J
    Semin Cancer Biol; 2015 Dec; 35():20-38. PubMed ID: 26392377
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of Mouse
    Zhao JY; Osipovich O; Koues OI; Majumder K; Oltz EM
    J Immunol; 2017 Aug; 199(3):1131-1141. PubMed ID: 28637900
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The solution structure of the human ETS1-DNA complex reveals a novel mode of binding and true side chain intercalation.
    Werner MH; Clore M; Fisher CL; Fisher RJ; Trinh L; Shiloach J; Gronenborn AM
    Cell; 1995 Dec; 83(5):761-71. PubMed ID: 8521493
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The SAM domain of human TEL2 can abrogate transcriptional output from TEL1 (ETV-6) and ETS1/ETS2.
    Vivekanand P; Rebay I
    PLoS One; 2012; 7(5):e37151. PubMed ID: 22615925
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structural studies of Ets-1/Pax5 complex formation on DNA.
    Garvie CW; Hagman J; Wolberger C
    Mol Cell; 2001 Dec; 8(6):1267-76. PubMed ID: 11779502
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ETS1 is coexpressed with ZEB2 and mediates ZEB2-induced epithelial-mesenchymal transition in human tumors.
    Yalim-Camci I; Balcik-Ercin P; Cetin M; Odabas G; Tokay N; Sayan AE; Yagci T
    Mol Carcinog; 2019 Jun; 58(6):1068-1081. PubMed ID: 30790340
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synergy of aromatic residues and phosphoserines within the intrinsically disordered DNA-binding inhibitory elements of the Ets-1 transcription factor.
    Desjardins G; Meeker CA; Bhachech N; Currie SL; Okon M; Graves BJ; McIntosh LP
    Proc Natl Acad Sci U S A; 2014 Jul; 111(30):11019-24. PubMed ID: 25024220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PEA3, Oct 1 and Oct 2 positively regulate the human ETS1 promoter.
    Chen JH; Wright CD
    Oncogene; 1993 Dec; 8(12):3375-83. PubMed ID: 8247540
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of MAPK specificity across the ETS transcription factor family identifies a high-affinity ERK interaction required for ERG function in prostate cells.
    Selvaraj N; Kedage V; Hollenhorst PC
    Cell Commun Signal; 2015 Feb; 13():12. PubMed ID: 25885538
    [TBL] [Abstract][Full Text] [Related]  

  • 58. EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes.
    Li R; Pei H; Watson DK; Papas TS
    Oncogene; 2000 Feb; 19(6):745-53. PubMed ID: 10698492
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Crystallization of the Ets1-Runx1-CBFβ-DNA complex formed on the TCRα gene enhancer.
    Shiina M; Hamada K; Inoue-Bungo T; Shimamura M; Baba S; Sato K; Ogata K
    Acta Crystallogr F Struct Biol Commun; 2014 Oct; 70(Pt 10):1380-4. PubMed ID: 25286944
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regulation of the transcription factor Ets-1 by DNA-mediated homo-dimerization.
    Lamber EP; Vanhille L; Textor LC; Kachalova GS; Sieweke MH; Wilmanns M
    EMBO J; 2008 Jul; 27(14):2006-17. PubMed ID: 18566588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.